Build a C. difficile stewardship: testing criteria, isolation, cleaning, and feedback.
- User
Build a C. difficile stewardship: testing criteria, isolation, cleaning, and feedback.
- Assistant
C. difficile Stewardship Program
Overview
Clostridium difficile (C. diff) infection (CDI) is a major healthcare-associated pathogen, responsible for significant morbidity, mortality, and costs. This stewardship program aims to optimize testing, reduce unnecessary isolation, ensure effective environmental cleaning, and drive continuous improvement through feedback. It aligns with IDSA/SHEA 2021 guidelines and promotes antimicrobial stewardship principles.
Goals:
- Reduce inappropriate testing by 30%.
- Achieve >95% compliance with isolation and cleaning protocols.
- Lower CDI rates by 20% within 12 months.
Program Leads: Infectious Diseases Physician, Infection Preventionist, Antimicrobial Stewardship Team (AST).
Implementation: Roll out via hospital-wide education, EHR alerts, and multidisciplinary committees.
1. Testing Criteria
Over-testing drives false positives, unnecessary treatment, and isolation. Test only high pretest probability cases.
Inclusion Criteria (Test if ALL met):
- Diarrhea: ≥3 unformed stools (Bristol Stool Scale 6-7) in 24 hours.
- New symptoms: Not tested in past 7 days (unless fulminant CDI suspected).
- No alternative cause: Laxatives, enteral feeds, or recent colonoscopy ruled out.
- High-risk factors: Recent antibiotics (past 90 days), hospitalization, age >65, immunosuppression, or prior CDI.
Exclusion Criteria (Do NOT test):
- Formed stools.
- Asymptomatic screening (e.g., admission, pre-transplant).
- Repeat testing within 7 days without clinical change.
- Post-cessation of diarrhea (>48 hours resolved).
Testing Algorithm:
Symptom Onset → Assess Stool Consistency → If unformed + high-risk → Order CDI PCR + Toxin EIA (2-step) - Step 1: GDH/PCR for detection. - Step 2: Toxin EIA for confirmation (treat PCR+/Toxin- as colonization).- EHR Order Set: Mandatory checkboxes for criteria + stool description photo upload.
- Frequency: Single test per episode; lab rejects non-compliant orders.
Metrics: Track test positivity rate (target <15%), inappropriate tests/month.
2. Isolation Protocols
Prompt isolation prevents transmission via spores.
Initiation:
- Suspected CDI: Isolate immediately on suspicion (stool pending).
- Confirmed CDI: Contact precautions until diarrhea resolves ≥48 hours AND off antidiarrheals.
Duration:
Patient Type Isolation Duration First episode Until 48h symptom-free First recurrence Until 48h symptom-free Multiple recurrences 48h after treatment + discuss extended (14 days) with IP Outbreak Extended per IP guidance Precautions:
- Single room preferred; cohort if limited beds.
- PPE: Gloves + gown for all patient contact; mask if aerosol-generating procedure.
- Patient Belongings: Dedicate equipment; limit visitors.
- Discontinuation Criteria: IP review; documented resolution + negative toxin test optional.
EHR Alerts: Auto-trigger isolation order on positive result; nurse flag for non-compliance.
3. Cleaning Protocols
C. diff spores resist standard cleaners; use sporicidal agents.
Daily Cleaning:
- Frequency: Twice daily + post-incontinent episode + discharge.
- Agents:
Surface Approved Agent Contact Time High-touch (bedrails, call buttons) Bleach wipes (1:10 dilution) or accelerated H2O2 10 min Floors/bathrooms Bleach solution (1,000-5,000 ppm) or peracetic acid 10 min Non-critical EPA Q-list sporicidal (e.g., OxyCide) Per label
Terminal Cleaning (Discharge/Transfer):
- Process: Top-to-bottom, remove visible soil first → sporicidal wipe/dwell → UV-C or H2O2 vapor if high-risk room.
- Verification: ATP bioluminescence testing (pass <250 RLU); fluorescent marker audit (monthly).
- Equipment: Dedicated C. diff carts; single-use where possible.
Training: EVS staff annual competency; post-CDI signage in rooms.
4. Feedback Mechanisms
Data-driven improvement via audits and reporting.
Surveillance & Reporting:
- EHR Dashboard: Real-time CDI rates (standardized infection ratio, SIR), testing compliance, isolation breaches.
- Monthly Report:
Metric Target Action if <Target Appropriate tests (%) >90% Education blast Isolation compliance (%) >95% Root cause analysis Cleaning pass rate (%) >95% Retrain EVS CDI SIR <1.0 Outbreak investigation
Audit Process:
- Prospective: 20 random tests/week (nurse/IP review).
- Retrospective: All positives; chart review for criteria adherence.
- Root Cause: Fishbone analysis for failures.
Education & Feedback Loops:
- Onboarding: Mandatory module for all staff.
- Feedback:
- Individual: EHR flags + email for non-compliant providers.
- Unit-based: Quarterly huddles with unit champions.
- Multidisciplinary: AST/IP meetings; celebrate successes (e.g., "Zero inappropriate tests week").
- Antimicrobial Link: Review antibiotics in CDI cases; auto-consult ID.
Evaluation:
- Quarterly program review by stewardship committee.
- Annual report to leadership with ROI (e.g., reduced isolation days = cost savings).
Appendices
- Quick Reference Card (printable):
C. DIFF STEWARDSHIP MANTRA: TEST SMART | ISOLATE FAST | CLEAN SPORES | FEEDBACK LOOPS - Contacts: IP pager [XXX], AST [email].
- References: IDSA/SHEA 2021 CDI Guidelines; CDC HICPAC.
This program is adaptable; pilot on high-incidence units. Questions? Let's investigate further. 🕵️♂️
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.